PESTEL Analysis of Australia's Medical Devices Industry
This paper applies a PESTEL framework to examine the medical devices industry in Australia. It explores the political landscape shaped by Senate inquiries into device regulation, the economic complexity of a multi-billion-dollar global market, and the sociological drivers of growing demand. It also considers future technological innovations such as exoskeletons and computer-driven implants, the legal challenges posed by product recalls and liability, and the environmental concerns surrounding hazardous substances used in device manufacturing. Together, these six dimensions reveal both the opportunities and regulatory challenges facing this industry.
- Introduction and Political Landscape: Senate inquiry and regulatory complexity in Australia
- Economic Dimensions of the Medical Devices Market: Global market scale and economic measurement challenges
- Sociological Drivers and Technological Innovations: Aging populations, demand growth, and future device technology
- Legal Challenges and Regulatory Oversight: Recalls, lawsuits, and shifting regulatory frameworks
- Environmental Considerations: Toxic substances in devices versus healthcare benefits
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper systematically applies the PESTEL framework, giving the analysis a clear and recognizable structure that allows readers to evaluate each external factor independently.
- It grounds abstract industry claims in specific figures and direct quotations from industry analysts and regulatory sources, lending credibility to each section.
- The paper balances industry-critical perspectives (e.g., recalls and toxicity concerns) with industry-supportive arguments (e.g., the benefits outweighing environmental risks), demonstrating fairness.
Key academic technique demonstrated
The paper demonstrates effective use of a structured analytical framework (PESTEL) as an organizational scaffold. Rather than writing a free-form discussion, the author uses each PESTEL category as a lens, ensuring comprehensive coverage of external factors. This technique is particularly useful in business and policy writing because it ensures no major dimension of the environment is overlooked.
Structure breakdown
The paper opens with the political and regulatory context, moves through economic and sociological factors, peaks with forward-looking technological speculation, and closes with legal and environmental concerns. Each section is self-contained but contributes to a cumulative picture of an industry under pressure to innovate while managing rising regulatory and ethical scrutiny.
Introduction and Political Landscape
The medical devices industry in Australia has become a focus for political leaders in recent years. The Australian Senate launched an investigation into medical device regulation in response to growing concerns about Poly Implant Prostheses (PIP) breast implants. According to Murphy (2012), "The inquiry, which is being conducted by the Senate's Community Affairs Committee, follows a senate committee inquiry into Australia's medical device regulation that was completed late last year and that generated 18 recommendations on how to improve the regulations" (p. 1).
Increased regulatory oversight is complicated, however, by the very nature of the medical devices industry. As Breton and Stinson observe, "The medical device world is a shapeless blob" (2010, p. 27). This point is reinforced by Egan (2001), who emphasizes that while a number of major pieces of legislation regulating medical devices have been passed in recent years, "Many small companies had taken no action as they do not regard their products as medical devices" (p. 194).
Economic Dimensions of the Medical Devices Market
The nebulosity of the medical devices industry makes its economic impact difficult to calculate (Breton & Stinson 2010). As these industry analysts write: "How much does a device cost? We have never been able to average prices of all devices, since both $0.99 Foley catheters and the $27,000 spinal implants will completely skew all analysis" (p. 27).
"Various quotes one can find on the internet place the device market in the billions of dollars. Just the manufacturing of devices was approximately $90 billion in 2006, and that does not take into account all the money spent on research and development, clinical trials, marketing, and distribution of samples of select products to physicians" (Breton & Stinson 2010, p. 27). Currently, the global medical devices market is estimated at $80 billion, with the United States accounting for approximately 50 percent of that total (Breton & Stinson 2010).
Sociological Drivers and Technological Innovations
Babies born today have a fifty-fifty chance of living to see their hundredth birthday, a process that will inevitably be facilitated by innovations in medical devices (Breton & Stinson 2010). There will therefore be increasing demand for these devices, fueled in large part by such innovations.
Although the industry may be a "blob," it is reasonable to conclude that future innovations will include exoskeletons that allow paraplegics to walk, the blind to see, and the mute to speak — outcomes that currently remain in the realm of scientific fiction. Computer-driven applications combined with improvements in mechanical devices will ultimately provide humans with a cyborg-like quality, and it is conceivable that people could live to be 200 years or more by the 22nd century, thanks to advances in medical technology. A joint industry statement supports this optimism, emphasizing that "New medical devices are designed to give better and earlier diagnosis, more effective and successful treatment and completely new treatments" (Joint Industry Statement 2007, p. 2).
References
Breton, T. & Stinson, C. (2010, January/February). 'The Medical Devices Industry.' Searcher, vol. 18, no. 1, pp. 26–27.
Egan, M. P. (2001). Constructing a European Market: Standards, Regulation, and Governance. Oxford: Oxford University Press.
'Joint Industry Statement.' (2007). European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry. [online].
Murphy, B. (2012, February 16). 'Australian device regulation under spotlight as PIP triggers Senate inquiry.' Scrip Regulatory Affairs. [online].
Create your account
Always verify citation format against your institution’s current style guide requirements.